Manager, Analytical Method Development
SK Life Science
Manager, Analytical Method Development
SK Life Science
Develops CNS and cancer therapies
The Manager/Sr. Manager, Analytical Method Development for Radiopharmaceuticals, is responsible for the development, optimization, validation, and transfer of analytical methods supporting radiopharmaceutical products across early- and late-stage development. This role requires strong technical expertise in analytical chemistry and a solid understanding of the unique challenges associated with radiopharmaceuticals, including short half-life materials, radioactive impurities, and time-critical testing. The position sits within CMC organization and works closely with Quality, Manufacturing, and external partners to ensure robust, compliant, and transferable analytical methods.
Analytical Method Development
Method Validation & Transfer
Radiopharmaceutical-Specific Testing
Documentation & Regulatory Support
Cross-Functional Collaboration & Continuous Improvement
Required
Preferred
Key Competencies
The anticipated salary range for this position is $120,000 to $140,000. Actual compensation may vary based on factors including experience, qualifications, skills, and business needs.
In addition to base salary, SK Life Science offers a competitive benefits package, including a 401(k) plan with company match and medical, dental, and vision coverage. Benefits are subject to eligibility requirements and may be modified at the Company's discretion.
Develops CNS and cancer therapies
SK Life Science is a U.S. subsidiary focused on developing medicines for central nervous system (CNS) disorders and cancer. Its work centers on researching and bringing pharmaceutical treatments to market that address neurological diseases and oncology, leveraging the broader SK Group’s resources and expertise. The company’s products work by targeting disease mechanisms in CNS conditions or cancer, delivered through conventional pharmaceutical formulations developed through its science-driven pipeline (as part of SK Biopharmaceuticals). What sets SK Life Science apart from competitors is its backing by SK Group and SK Biopharmaceuticals, enabling strong research, development, and global scale, as well as a stated commitment to real patient impact in CNS and oncology. The company aims to transform lives by delivering meaningful treatments that improve outcomes for patients with CNS disorders and cancer.
Explore more opportunities at SK Life Science